One of the more striking characteristics of human civilization has been his attempts to use his intelligence to seek relief from his various bodily ailments. His original efforts were entirely empirical like a game of ‘Blind Man's Buff’. There is a record of these early activities in a museum in Heidelberg which authentically recreates the official pharmacies of folk-lore medicine that operated in Germany from the 14th to the 18th centuries. In their day, these pharmacies administered the official pharmacopoeias, the currently accepted list of remedies and nostrums of the day. The museum shows how the pharmacopoeias kept changing. As products fell into disfavour, new products appeared to fill the gaps. We now know that many diseases will ameliorate for a time by giving biologically inert-substances – placebos. So, from a therapeutic point of view, were these drugs intrinsically useless? Probably most of the remedies were indeed worthless. But folk medicine had its successes; some of them are still used in modern medicine. The roots of the belladonna plant are a source of atropine, the leaves of the foxglove are a source of digitalis, and the seeds of a common poppy provide morphine. How people originally found out about the therapeutic properties of these plants is truly a mystery. This empirical approach to therapeutics based on trial and error did not give way to an empirical one based on scientific knowledge until the middle of the 19th century. In 1856, William Perkin, then 18 years old, was doing amateur chemistry experiments on the top floor of his parent's home in London (Harrow, 1921). At that time, London was heated and lit by gas derived from the distillation of coal, a process that produced by-products, including coal tar. Professor Hofmann, Perkin's tutor, had shown him how naphtha extracted from coal tar could be converted to the artificial alkaloid known as naphthalidine, and Perkin was trying to convert this artificial alkaloid into a drug, the natural alkaloid, quinine. Quinine had come to Europe from South America in the 17th century where its antimalarial properties had been discovered by folk medicine. It was in short supply and very expensive but vitally important to prevent malaria which was rampant in many parts of the world. Perkin's experiment failed but he did produce a magnificent new colour – mauve, the first aniline dye. Mauve led to a whole new industry for synthesizing artificial dyestuffs and thence to the development of explosives, perfumes, photography and modern therapeutic drugs. After Perkin's experiment, the next contribution of dyestuffs to medicines came from Paul Ehrlich who was born 2 years before Perkin made his great discovery. By the time Ehrlich went to university, he had developed a passion for the microscopy of animal tissues, mounted on glass slides and stained with aniline dyes. Although he was not the first to use aniline dyes to stain tissues, he was the first to develop a theory on the staining process. He graduated in medicine when he was 24 and his graduation thesis on ‘On the theory and practice of histological staining’ was remarkable. His early ideas about the chemical affinity of dyes would lead him on to his work with von Behring on antitoxins and his concepts of serum therapy. Due to his work on antitoxins he developed his ideas about receptors (Maehle et al., 2002). He imagined that cells sprouted finger-like processes that, with specific receptors expressed on their surfaces, could bind toxin molecules on a one-to-one basis. This receptor idea turned out, years later, to be the basis for the invention of many new drugs. Then he discovered that living cells in tissue culture, as distinct from pieces of dead tissue fixed in blocks of wax, could be selectively stained by another dyestuff, methylene blue. From this, he developed the idea of chemotherapy as a concept-driven goal. What he wanted was to find dyestuffs, like methylene blue which would selectively bind to receptors on the surface of living cells but which, unlike the blue dye, would be toxic and would kill the cell. He knew that many dyestuffs were organic compounds of the well-known poison arsenic. He therefore set out to screen organic arsenicals for with the that had been discovered to be the of he He first that the to an organic and a toxic was – in chemical he that was not the that but a and to from this, he its chemical ideas that he had developed in a of the chemistry of new was into with the was then the next was was a then he wanted to know the was the toxic a he as the therapeutic in he found a that was and had a therapeutic et al., It was the that he had and and as the known as Ehrlich was truly the of modern and of the modern was another still a he the in and first the of with gas and He his the and an and In he a of as and was by Ehrlich to their dyes in He of new in – and In this he discovered the of but was that a that was in would be in his fell with a In he with and made a He one about this experiment until the of human were in was the of and the The most to has been Paul a who his and his in the by from a that had been into medicine in as an for and was found to properties and of its properties could be for its wanted to he could the is a and he knew that chemistry was he to its and the properties of the new molecules The first known as the is when a is with an and its In the a of in in a is The tissue but when an is to the these are By synthesizing and new compounds these he a of the specific chemical for the properties – now them and are the of modern he by new drugs. were a and a and are still drugs as from years of was of an of chemical that he to as as his knew had his of chemical blocks that had for him in the From then led to and and he and to new drugs. one has great and a of to discovery. from molecules that knew had for tissue new compounds in whole in in and used the of these to new molecules based on ideas about used the approach that had as the basis of Although of them had an for their to lead to a invention based on that were were – and one to them from their – with their as as was to their – not the of a but the of that a was for that and more to with with new with a point which is known to tissue Ehrlich and from dyestuffs, by from a known as an to its for in from the knowledge of the of the drug, which was used that time for the relief of in from an idea for and the with that to the of was known to be the of the by So, in the early the efforts were to trying to the After for years had been for the of an would with their and a the were that relief was with a It was that a was in the relief the of to find their been new drugs that were in but in The to the to the by the to the surface of the in therapeutic From was to and a who had with in to develop an idea that he had he was with His idea was to the of by the He that when a in the of is of developed 2 when the were in a with 2 then of in the time knew that was with the of a of an the was by the in the – and has a very in that the in to by idea was that a in supply was an in the for would be The of is The of is the of in the to the The to with the of and It was known the time that the and cells by the of was still to be wanted to find a that would the of on the the is to in the a of of the of would the properties of to with In the and by of the in the the of the time would We knew this was of the on of the drugs that had been by in the drugs had on when the were but when their fell and and the the and the of So, idea of to its – could had the in that from in would be by a in the Although was to that time, in the first of a new on in by and found a on by He was to use this to his original He had had great his original work and ideas accepted but his was in the of the was a and for the next years more his work was was very but for that a had been in a had been to the properties of a very of had to the and the but had to he had that were of receptors which he and It was this that and molecules their by on receptors on the surface of the cells that was and that found to He that when was to and was but when was receptors to the and the was on He that drugs were of receptors and led to the in on and had known that the on was by a in a receptor In his was a receptors which its use for by the a which was by the drugs were receptors to a in on This was the first time that the receptor idea had been used to the properties of and drugs to It was now to that wanted was a the that in the were in his how he that his and receptors were not like on a that their his that in he had made an invention now know that he had made a that indeed as new to with a chemical Ehrlich and from dyestuffs, from in from the knowledge of the of the drug, which was used that time by to by and the idea was based on the of and their receptors as that a that is now used in to and about receptors in about has when a The with of receptors is that not that the and use the to the receptors that and in the idea of a a derived from the for and that when the of the the chemistry of the the of a into the by cells that the of the their new the to into the had a for – a new idea in in to this time, had in of – that the of were by the of found many molecules that are into the and are to in the not a to the is by not that receptors on their of the come from the as the and and the are and to to and on the basis that a is not is not a now know that of the of cells that to by out chemical now many of molecules but to them as that are that are used in a and that a to to There are of these molecules with their them one that of with the of But are not when are the years the of ideas about and their receptors has been years about but the to about their The people who about receptors were a of who to the the of the of the and of the tissue their the molecules of the to on a one-to-one with that time, tissue molecules The of were by the of their In years in the of a receptor in chemical first used by to the tissue of on and for the of specific molecules et al., The from and and and who that receptors could be extracted from as chemical be on and as as et al., products of this about in in and will still be years from In the of that be by As years in is by the of new concepts and not by the of and are but concepts and ideas are new has to an one and concepts be the that first bind selectively to its specific known as the and then the the to its the known as In the and that, in a of affinity and were now known as could be some of affinity therefore known as affinity for the compounds could now with the for receptor and would the their as In this receptor affinity to the of receptors and its is of receptor and its be on is a of receptors and its will from tissue to a like a on a tissue with receptor and a on another tissue with receptor first before this was by by wanted to find a for its The of to point to how a in theory but to practice had to know the in and him was in by of their to in their in to accepted and in new the to work on the The of was to the of this, was to use the the used in The was to the chemical point for chemical is derived from an that is one of the blocks of and the source of a known as It is an with a one of a and a the has to the and has a to the is a chemical of an of the on the – the from to did not the of receptors that would from the for the and could from this that the to the receptors was a of the of the would be with the of the the – but did We with the of the and the with and and The chemical of – the point of the for a early in came a that the properties of the of known as and the were trying to a by the of with did not had its In their that the had been with to its but about the of the and for and found that was as an as on As had idea this the was was trying to develop a new The used with the that the of the was a of in and of a the of of from the of but a from a point of view, were and were short and was to develop a from some of this new did not the of but now the produced by into the the next He the a and a his was that the on the had about the as a but the of the We found on the that this new the of on the but did not its on the another and many new were before invention of the first to the the of et al., did indeed give relief to with but not as as the that were made in the was that were very the of with and unlike drugs that time, did not people The was that some did develop In the of in and in the a in their use for first contribution to new It into an in ideas about as chemical molecules and their The chemical of the with the known of a of the natural The were based on the of the to be that would the of where the of molecules could be to in processes but by a was work on had in in the in where had the of with had a a who had from a the for where he was He that to the of He In the found that did indeed and the of about his work on the development of the that he was to the of the to the of in the of In this he used of the to the very of that including that the of by was not by the this work as was the the to its was to an in was in in how the of the about about and the of the In he had found a by which was into the by a of the the He was a and that the and an of the of the but did not He the new for was shown that of tissue would Then these were shown to that could There was of in the could be the So, to in that is et al., in was an who had been a of the great in was now Professor of in had been with of – that the of was by had that was a that and was about the that and were – he his and to work on the In came from where he had his work with William on the new to be a with that of the to the in its was in a next He was a who that was a and not a like then a of was He that a by the that was not who had with in the the when he to By he had extracted from of He that was a The was then by his The was that had its and was now for in the of and was a in that of from in He was a in the which from the He was that, in the that and the and of in the So, the to and this by the drugs not was that were and receptors that would to the and then on its receptors to of and and would be receptor In be on its receptors to to to these and receptors as and that could find a would be to the and and and were found a way of the of that was the in and This was is to as with a of and very the had to to another invention is a and in their with which is like derived from an is a with a of known as an one and a in a the We by the of was the that was to by in the found a that turned into a the of The the of and This was for the of a knew that was on the This was to be the that kept for the next that a by the of with the and the came from the with the The with its the of affinity for the came from the of by was the with the that be So, from a chemical point of view, the but did It years of and chemistry before found that the with a produced a that was a on but a to on The of was to was to the of that the to the produced more led the chemical that in which was as et al., The chemical of This about years from to and the was was – indeed by its receptors on the cells to the that the the cells to in the of the turned out to be to of and the of who had had to with now had to was a The with was that the had in many of them that a to produce in the first was still and produced the had on to that the of By this time, et al., had discovered that not the cells to but them to and a known as when the was now more from the and was a of this be in way to find out would be to a receptor is a that is of a of of the of is by the known as We made a when that this into a and 2002). developed some in in the set about trying to that had but the next made many that in the in but which failed to be drugs when were in to properties as from the by the for that will in the In the has been that in the of be with the in the of of the and The new the are by some are that a new receptor to We shown in a that one of of but which has to be by more the of with We now know that cells develop receptors and like cells to to by an in their of So, time with their of this is is known as the time that be in new invention – as been on the In of these in chemistry to a and its This the invention of receptor has been used by many the invention of many has been one of the great of the This is the to that is to a for is the set of that one to to in the with the in are based on and about the work of with a to develop a new with a new of that, in would therapeutic before that the is of expressed by a There be empirical that drugs are known to that and then is to when the is is of the that will the to be the is to be based on and from the There be an chemical a with the The chemical be an known be a a lead by – but to There has to be a which the specific imagined to the – in a is to a to be to how will be to in that the has the as would found in the to a in in which would be to the new one of about the – as as when to be – then is be a of to the the that is is to to a new receptor the process in the the chemical of a is the in his the and to the chemical that be by an of the The and of still more The new has to be by a of tissue tissue that to the The new be – is still – and then in with the – the At this are as as the new chemical new compounds to be made and This – – has been shown to work compounds with a of are by to very been the for new drugs in the industry as known for the years an has been The for medicines in the of relief from is will on medicines in to many of and in a with and a of the for drugs and will to The of the is that the of is as development The of and development been of for and by the of the new the has been from and to the of drugs. and development had to the of the of as Ehrlich and are as their approach by the of new new are based on in and for now be extracted from cells as products and expressed on the of glass on expressed with the receptors when a to the and receptor molecules in a in a In this and screen many of molecules in a day. This is known as known as has developed chemical were developed to the of It is important to that with that to as of the molecules that were made by the could not been produced by has now been by of from of of used to be now is the of the new is now to be with a in The for the now is that the the as out There be some in that but to the of of The first is that these are a source of new As a lead and as that as an in and to been for years before the years natural had first to the of chemical to develop of molecules that were with before a basis for could of the of that the most with the therapeutic come when the lead was a drugs that are a natural some of the first to the is that not the that the new the and still years to As to the of the new are that the of compounds into early are to the of compounds that the of this to that when by the used in how knowledge of and the that the of been by the scientific process of has to be most and the and of whole into their and and then into the various cells that these and these cells into the of that are the of modern and cells are of these as with a that, like the idea of is more the of its are to as are to and are to The of and into and is not about the of is that is on that this when the new drugs that the industry is to as and are to be to the that to and that this not be As the has to with the and is about how cells use to to the has the of a as is the to the of the in a that blocks the of on the that the to on but very The process of is of most drugs by with chemical that to are like As these processes are as an a in by the with his and with his the – by the and – cells with are and the of The cells are by from the and by from the cells in the are by and by As as this is a that to that The that has been is how the and is the At a is to some of about which efforts more by is another of that be but which, of these are of of and new these are are like So, how are these processes that be on but The striking of these processes is that many chemical are a of these molecules is that be shown to a process that that an the of more one a giving a not a but a of as The are chemical which to on the the time to its This to by chemical the of the of a be has been the of various molecules known to be in in in At some point the way of is is in this the is that are by chemical based on will to them There is now a not that has a on the We to develop a to to the In this not to for in the of new to by how the of as a chemical could not been made is the is in the in the the of drugs on in At one time, the way to the of drugs on was by in its the was into a In this found that had indeed the for could be made on of where was and his when found that now had the on He went on to that the was in the but was in the by the of a He that by the to a that into the This was when the and were in as were in a We now know that the is a which when cells are in this could not been made by the of and the is that, in these in that would be by the chemical So, how in the We and the and then come then pieces of with their in then cells in tissue culture, then cells in one of by a of one is more then that to be the of by the of the The of for the of in the first is the tissue The of these is that be and in as many as and still and So, that which were by the modern industry as still an important in In his he that the from his be in the of to who the on In his on the of his about the of practice the to There be that the and of new drugs made a contribution to that In this to that the invention of new drugs could still an and to to the of as The is not for the of by the be to the for the
No takes yet. Share an insight, caveat, or question.
J.W. Black (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: